BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Diagnosis
10 results:

  • 1. sil-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
    Barak V; Kalickman I; Pe'er J
    Anticancer Res; 2022 Mar; 42(3):1447-1453. PubMed ID: 35220238
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Value of Contrast-Enhanced Ultrasound liver Imaging Reporting and Data System in the diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
    Peng J; Zhang T; Wang H; Ma X
    J Ultrasound Med; 2022 Jun; 41(6):1537-1547. PubMed ID: 34617296
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Phase I study of low-dose metronomic temozolomide for recurrent malignant gliomas.
    Wong ET; Timmons J; Callahan A; O'Loughlin L; Giarusso B; Alsop DC
    BMC Cancer; 2016 Nov; 16(1):914. PubMed ID: 27876012
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. IL-15/sil-15Rα gene transfer suppresses Lewis lung cancer growth in the lungs, liver and kidneys.
    Sun H; Liu D
    Cancer Gene Ther; 2016; 23(2-3):54-60. PubMed ID: 26742578
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. cancer biomarker profiling in patients with chronic hepatitis C virus, liver cirrhosis and hepatocellular carcinoma.
    Costantini S; Capone F; Maio P; Guerriero E; Colonna G; Izzo F; Castello G
    Oncol Rep; 2013 Jun; 29(6):2163-8. PubMed ID: 23564159
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Primary hepatic peripheral T-cell lymphoma treated with corticosteroid.
    Miyashita K; Tomita N; Oshiro H; Matsumoto C; Nakajima Y; Ito S; Matsumoto K; Fujita H; Ishigatsubo Y
    Intern Med; 2011; 50(6):617-20. PubMed ID: 21422689
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. diagnosis of a previously unidentified primary site in patients with spinal metastasis: diagnostic usefulness of laboratory analysis, CT scanning and CT-guided biopsy.
    Iizuka Y; Iizuka H; Tsutsumi S; Nakagawa Y; Nakajima T; Sorimachi Y; Ara T; Nishinome M; Seki T; Takagishi K
    Eur Spine J; 2009 Oct; 18(10):1431-5. PubMed ID: 19533181
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Circulating interleukin-6 predicts survival in patients with metastatic breast cancer.
    Salgado R; Junius S; Benoy I; Van Dam P; Vermeulen P; Van Marck E; Huget P; Dirix LY
    Int J Cancer; 2003 Feb; 103(5):642-6. PubMed ID: 12494472
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Clinical study of infection associated hemophagocytic syndrome].
    Shiraishi K; Tanaka K; Okubo Y; Sakamoto A; Jojima H; Fukahori S; Fujimatsu Y; Shiraishi T; Honda J; Oizumi K
    Kansenshogaku Zasshi; 2000 Aug; 74(8):630-7. PubMed ID: 11019510
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein.
    Izzo F; Cremona F; Delrio P; Leonardi E; Castello G; Pignata S; Daniele B; Curley SA
    Ann Surg Oncol; 1999 Mar; 6(2):178-85. PubMed ID: 10082044
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.